BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa

Search

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
3/29/17 Novartis (NVS) CTL019 for Acute Lymphocytic Leukemia (ALL) Subscribers Only Subscribers Only Subscribers Only
3/29/17 Acorda (ACOR) CVT-301 for Parkinson's Disease (PD) Subscribers Only Subscribers Only Subscribers Only
3/29/17 Roche (RHHBF) MabThera (Subcutaneous) for Indolent Non-Hodgkin's Lymphoma - NHL Subscribers Only Subscribers Only Subscribers Only
3/29/17 Amgen (AMGN) Blincyto for Acute Lymphocytic Leukemia (ALL) Subscribers Only Subscribers Only Subscribers Only
3/29/17 ARMO AM0010 for Pancreatic Cancer Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
03/30/17 Subscribers Only Subscribers Only Trial Announcement - Initiation
03/30/17 Subscribers Only Subscribers Only Trial Data - Other
Now - 03/31/17 Subscribers Only Subscribers Only Trial Announcement - Trial Completion
Now - 03/31/17 Subscribers Only Subscribers Only Trial Announcement - Initiation
Now - 03/31/17 Subscribers Only Subscribers Only Trial Announcement - Initiation